´ëÇѺñ´¢±â°úÇÐȸ 2018 KPS-APSU Joint International Symposium : 2018-09-01 ±³À°ÀÏÀÚ : 2018-09-01
±³À°Àå¼Ò : ¼¿ï¼º¸ðº´¿ø ¸¶¸®¾ÆȦ
±³À°ÁÖÁ¦ :
2018 KPS-APSU Joint International Symposium ÁÖÃÖ±â°ü : ´ëÇѺñ´¢±â°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÀü¸³¼±ÇÐȸ
´ã´çÀÚ : È«¼º±Ô
¿¬¶ôó : 02-556-7473
À̸ÞÀÏ :
soyeon@iztec.co.kr ±³À°Á¾·ù : ºñ´¢±â°ú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 55ºÐ
¼¼ºÎ¼ö°·á : 150,000¿ø
ºñ°í »çÀüµî·Ï (6/1~8/20) ÀÇ»ç 10¸¸¿ø / °£È£»ç ±× ¿Ü 7¸¸¿ø ÇöÀåµî·Ï (8/31~9/1) ÀÇ»ç 15¸¸¿ø / °£È£»ç ±× ¿Ü 7¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 09:00~09:15 Management of Lymph node-positive penile cancer ÀåÀÎÈ£(Áß¾Ó´ëÇб³º´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 09:15~09:30 Contemporary retroperitoneal lymph node dissection for testis cancer ½É¸í¼±(ÇѸ²´ë¼º½Éº´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 09:30~09:45 Tamsulosin 0.4mg use in Asian Patients ÇÏÀ¯½Å(¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 09:45~10:00 Panel Discussion Stephen J. Freedland (USA)Lukman Hakim (Indonesia)Á¤Å¿µPeter Mulders (Netherlands)ÇãÁ¤½ÄGiuseppe Procopio (Italy)¹Ú½ÂöBannakij Lojanapiwat (Thailand)(Cedars-Sinai, USAAirlangga UniversityÁß¾Óº¸Èƺ´¿øRadboud University Medical Center Nijmegen, The NetherlandsÁ¦ÁÖ´ëÇб³º´¿øFondazione Istituto Nazionale Tumori, Milan, Italy¿ø±¤´ëÇб³º´¿øFaculty of Medicine, Chiang Mai University, Chiang Mai, Thailand)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 10:20~10:35 Focal therapy elilgibility determined by mpMRI or mpMRI/US fusion Biopsy ÀüȲ±Õ(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 10:35~10:55 Molecular imaging in the management of prostate cancer Robert Reiter (USA)(UCLA, USA)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 10:55~11:15 How to manage node-positive prostate cancer ÇÏÈ«±¸(ºÎ»ê´ëº´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 11:15~11:30 Practical Guidance on the comorbidity in the treatment of mCRPC Á¤À翵(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 12:40~13:00 Optimalization of imaging in renal tumors: use of CAIX antibody Peter Mulders (Netherlands)(Radboud University Medical Center Nijmegen, The Netherlands)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 13:00~13:15 The role of arterial embolization in RCCa ±èÇöÅÂ(Ä¥°î°æºÏ´ëÇб³º´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 13:15~13:30 Indication of renal biopsy in renal tumors Á¤Àΰ©(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 13:30~13:50 Current strategies and future challenges in 2nd line therapy in advanced RCC Giuseppe Procopio (Italy)(Fondazione Istituto Nazionale Tumori, Milan, Italy)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 13:50~14:00 Panel Discussion ¼Û丰Lukman Hakim (Indonesia)È«¼ºÈÄRobert Reiter (USA)°íÁؼºBannakij Lojanapiwat (Thailand)ÀÓÀ缺Stephen J. Freedland (USA)(¼¿ï¾Æ»êº´¿øAirlangga University¼¿ï¼º¸ðº´¿øUCLA, USAºÎõ¼º¸ðº´¿øFaculty of Medicine, Chiang Mai University, Chiang Mai, ThailandÃæ³²´ëº´¿øCedars-Sinai, USA)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 14:20~14:40 NMIBC BCG unresponsive disease Seth Lerner (USA)(Baylor College of Medicine, USA)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 14:40~14:55 Urine Markers for Bladder Cancer À±¼®Áß(ÃæºÏ´ëÇб³º´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 14:55~15:10 Enhanced Technique Endoscopic Visualization in NMIBC °¼®È£(°í´ë ¾È¾Ïº´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 15:10~15:25 Role of IO in NMIBC ¼È£°æ(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 15:40~16:00 Neoadjuvant treatment prior to prostatectomy in High-Risk Disease À¯´Þ»ê(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 16:00~16:15 Local Treatment in Patients with Newly Diagnosed Metastatic Disease: Myth or Reality? ±Ç¼¼À±(µ¿±¹´ë°æÁÖº´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 16:15~16:30 Current management of hormone sensitive prostate cancer À̽Âȯ(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 16:30~16:50 CRPC: definition and treatment options Stephen J. Freedland (USA)(Cedars-Sinai, USA)
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 16:50~17:00 Panel Discussion Shigeo Horie (Japan)Seth Lerner (USA)ÈÁ¤¼®Hideyuki Akaza (Japan)±è¼±ÀÏLukman Hakim (Indonesia)±è¼öµ¿Rainy Umbas (Indonesia)°í¿µÈÖÀÌ»óÀº(Graduate School of Medicine, Juntendo University, Tokyo, JapanBaylor College of Medicine, USA°æ»ó´ëÇб³º´¿øResearch Center for Advanced Science and Technology, University of Tokyo, Japan¾ÆÁÖ´ëÇб³º´¿øAirlangga Universityµ¿¾Æ´ëÇб³º´¿øUniversity of Indonesia¿µ³²´ëÇб³º´¿øºÐ´ç¼)